Information Services Group (ISG) has named DXC Technology a digital transformation “leader” in six critical categories in its ISG Provider Lens Global Quadrant Report on Digital Business Transformation.
Spend analytics information must be used — not just viewed — by all stakeholders to derive best value and outcome.
Pharmaceutical and biotechnology companies are under pressure to manage their complex pricing environment in the wake of new state laws on price transparency.
DXC's suite of Business Process Services (BPS) spans the full life cycle of regulatory related needs – from the beginning of the R&D process, through product development, marketing and ongoing maintenance.
DXC provides planning and regulatory content management tools that span the life cycle through to publishing, submissions and tracking.
DXC’s Regulatory Transformation Services help you manage your activities across the entire regulatory information management (RIM) life cycle.
DXC's services position companies to respond rapidly to market and technology changes with minimal risk.
UK-based Allergy Therapeutics is enjoying the benefits of a streamlined regulatory submission process following a cost-effective upgrade to the latest version of FirstDoc.
When one of the world’s largest manufacturers of pharmaceuticals and consumer healthcare products needed to modernize its BI environment, it turned to DXC for help.
Life sciences companies must leverage the tools and knowledge of other industries to improve drug discovery, development, manufacturing and market access, and introduce new concepts.
Having an atomic knowledge base shifts the dial away from document-oriented searching to knowledge-oriented searching.
Regulatory intelligence encompasses many other areas of the product life cycle, including clinical research and development for detailed analysis and safety and pharmacovigilance for signal detection.
DXC Technology is proud to be sponsor of DIA 2019 Global Annual Meeting, June 23-27, in San Diego, CA.
View this webinar to learn about the power of the next-generation connected Life Sciences platform.